AlphaTON Capital Corp.
ATON
$5.62
-$0.05-0.88%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
9/8/2025
-
TipRanks Financial Blog
9/8/2025
-
The Fly
9/8/2025
-
TipRanks Financial Blog
9/8/2025
-
The Fly
9/3/2025
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, July 25, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 25 and 29 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
302 219 5556
Address
Clarence Thomas Building
P.O. Box 4649 - Road Town
Tortola, VG1110
P.O. Box 4649 - Road Town
Tortola, VG1110
Country
Year Founded
--
Business Description
Sector
AlphaTON Capital Corp., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-3, a...
more